2025 Vault Rankings
At a Glance
“Colleagues and work/life balance.”
“Highly collaborative environment.”
“The people and the continuous revolving door of interesting projects.”
“Busy periods can be draining.”
“Lack of formal structure.”
“The work can be busy in a boutique setting when things come in all at once.”
About Back Bay Life Science Advisors
Back Bay Life Science Advisors provides life science strategy and investment banking to pharma, biotech, medtech, and healthtech companies around the globe. Back Bay collaborates with investors, banks, academia, and government to advance treatments in human care.
From its offices in Boston, Back Bay teams provide consulting services to those on the forefront of the ever-evolving field of life sciences.
Back Bay works with companies of all sizes across the US and global life science markets, across every stage, sector, geography and therapeutic area. Back Bay strategy and banking teams guide companies on technology and drug development, from planning and initial concept to product commercialization, franchising and licensing, M&A, divestiture, and more.
With headquarters in Boston's Back Bay neighborhood and offices in Toronto, Back Bay also has a strong footprint in Europe, particularly the Nordic markets.
545 Boylston Street
Boston, MA 20116
Phone: (617) 236-0954
Co-Founder, Managing Partner, CEO: Jonathan P. Gertler, MD
Managing Director, Head of Investment Banking: Gregory Benning
2023 Employees (All Locations): 30
Boston, MA (HQ)
Toronto, Canada
Biopharma, medtech and healthtech development, product pipeline and lifecycle advisory, integrated with investment banking guidance and execution. Functional practice areas include:
- Franchise, business unit & therapeutic area strategy
- Competitive intelligence
- Asset & development prioritization
- Platform implementation
- Payor/Pricing strategy
- Contracting strategy
- Launch & counter-launch strategy
- Product positioning, branding & messaging
- Life-cycle management
- Corporate growth strategy
- Liquidity & exit planning
- Mergers, acquisitions & divestitures
- Private & public company, cross-border capabilities
- Partnering & strategic alliances
- Financing support
- Fairness opinion, valuation
- Registered broker-dealer
- Biotech
- Medtech
- Healthtech
- Investors